APP and Alzheimer disease: After i.v. injection, it can rapidly penetrate the BBB and produce approximately 1.3-fold higher brain fluorescence in APP/PS1 AD mice than that in the age-matched WT mice at 10 min, which increased to ~1.5-fold at 30 min.